Company · CIK 0002091349 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
First Tracks Biotherapeutics, Inc. · TRAX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:05 pm EDT | John A OrwinDirector | 1,300 | — | — | 17,995 | — | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | $44.78 | $1,758,145 | 15,660 | −71.5% | |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | $5.74 | $225,381 | 54,925 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Rita JainDirector | 7,330 | — | — | 19,194 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | John P. SchmidDirector | 6,030 | — | — | 37,652 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | John A OrwinDirector | 6,030 | — | — | 16,695 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | J. Anthony WareDirector | 6,030 | — | — | 15,660 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Magda MarquetDirector | 6,030 | — | — | 15,960 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Dennis M FentonDirector | 6,030 | — | — | 10,995 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:05 pm EDT | John A OrwinDirector | 1,300 | — | — | 0 | — | |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | — | — | 0 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Benjamin StoneChief Business Officer | 60,492 | — | — | 137,651 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Paul F. LizzulChief Medical Officer | 60,492 | — | — | 137,651 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Daniel FagaPresident, CEO, Director | 193,575 | — | — | 440,485 | — | |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:26 pm EDT | Benjamin StoneChief Business Officer | 60,492 | — | — | 77,159 | — | late |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:25 pm EDT | Paul F. LizzulChief Medical Officer | 60,492 | — | — | 77,159 | — | late |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:24 pm EDT | Daniel FagaPresident, CEO, Director | 193,576 | — | — | 387,156 | — | late |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Rita JainDirector | 7,330 | — | — | 0 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | John P. SchmidDirector | 6,030 | — | — | 0 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | John A OrwinDirector | 6,030 | — | — | 0 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | J. Anthony WareDirector | 6,030 | — | — | 0 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Magda MarquetDirector | 6,030 | — | — | 0 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 4:05 pm EDT | Dennis M FentonDirector | 6,030 | — | — | 0 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:09 pm EDT | Dennis M FentonDirector | 9,500 | — | — | 7,000 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:09 pm EDT | Rita JainDirector | 9,500 | — | — | 7,000 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:08 pm EDT | Magda MarquetDirector | 9,500 | — | — | 7,000 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:07 pm EDT | John A OrwinDirector | 9,500 | — | — | 7,000 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:06 pm EDT | John P. SchmidDirector | 9,500 | — | — | 7,000 | — | |
| May 12, 2026 AForm 4/A → | Jun 12, 4:01 pm EDT | J. Anthony WareDirector | 9,500 | — | — | 7,000 | — |